Global Cell and Gene Therapy Market

Feb 2022| BIO225A| BCC Publishing
Sample Report

Report Highlights

The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.

Report Includes

  • 20 data tables and 25 additional tables
  • An overview of the global market for cell and gene therapy (CGT) products and their applications
  • Analyses of the global market trends, with historic data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the overall market size for cell and gene therapy, forecasted growth trends, and corresponding market share analysis by product type, therapy type, application, and region
  • Highlights of the upcoming market potential of cell and gene therapy products and areas of focus to forecast this market into various segments and sub-segments
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors that will drive future demand for this market
  • Identification of novel therapeutic products and promising new technologies still in the development and testing stage, and assess the probability that they will be commercialized successfully in the next five years
  • Review of emerging companies and the leading competitors in the prevailing cell and gene therapy market, and their global company share analysis
  • Impact of COVID-19 pandemic on cell and gene therapy market and related biotech industry
  • Review of pipeline analysis and the total number of CGT clinical trials by clinical trial phase, disease indication, and geography
  • Descriptive company profiles of the major global players, including Novartis, Orchard Therapeutics plc, Pharmicell Co. Ltd., Sibiono Genetech Co. Ltd., Vericel Corp. and Bristol-Myers Squibb Co.

Report Scope

The current report provides detailed exposure to the cell and gene therapy market. This report also highlights the current and future market potential of CGTs along with a detailed analysis of the drivers, restraints, and opportunities in the market. The report also covers market projections to 2026 and market rank for key market players. It also covers the competitive environment and includes a pipeline analysis. The report details the market share of CGTs based on product and by application. The market is segmented into rare diseases, oncology, hematology, cardiovascular, neurology and others based on application. The scope of the report does not include RNA-based products.

By region, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North America region includes countries such as the U.S., Canada and Mexico, Europe includes countries Germany, U.K., France, and Rest of Europe, and the Asia-Pacific includes countries China, Australia, Japan, and Rest of Asia-Pacific. For market estimates, data have been provided for 2019 as the historic year, 2020 as the base year and a forecast for 2026.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Global Cell and Gene Therapy Market108 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Cell and Gene Therapy: Background and Technology7$363Free
Chapter- 4: Market Dynamics8$415Free
Chapter- 5: Market Breakdown by Therapy Type13$675Free
Chapter- 6: Market Breakdown by Product10$519Free
Chapter- 7: Market Breakdown by Application8$415Free
Chapter- 8: Market Breakdown by Region17$882Free
Chapter- 9: Impact of the COVID-19 Pandemic5$259Free
Chapter- 10: Pipeline Analysis6$311Free
Chapter- 11: Competitive Landscape4$208Free
Chapter- 12: Company Profiles19$986Free
Chapter- 13: Appendix: List of Acronyms2$104Free
Global Cell and Gene Therapy Market

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.